R. Michael Hendry

3.8k total citations · 1 hit paper
54 papers, 3.0k citations indexed

About

R. Michael Hendry is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, R. Michael Hendry has authored 54 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Infectious Diseases, 27 papers in Virology and 23 papers in Epidemiology. Recurrent topics in R. Michael Hendry's work include HIV Research and Treatment (26 papers), HIV/AIDS Research and Interventions (17 papers) and Virus-based gene therapy research (11 papers). R. Michael Hendry is often cited by papers focused on HIV Research and Treatment (26 papers), HIV/AIDS Research and Interventions (17 papers) and Virus-based gene therapy research (11 papers). R. Michael Hendry collaborates with scholars based in United States, Brazil and Zimbabwe. R. Michael Hendry's co-authors include Steven A. Feldman, Judy A. Beeler, Lynette Sawyer, Jayashree Pyati, Dennis R. Burton, David D. Ho, Eileen Garratty, E. Richard Stiehm, Peter L. Nara and Carlos F. Barbas and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and PLoS ONE.

In The Last Decade

R. Michael Hendry

53 papers receiving 2.9k citations

Hit Papers

Efficient Neutralization of Primary Isolates of HIV-1 by ... 1994 2026 2004 2015 1994 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Michael Hendry United States 28 1.5k 1.4k 1.1k 863 492 54 3.0k
Rigmor Thorstensson Sweden 38 2.2k 1.4× 1.3k 1.0× 1.4k 1.3× 1.5k 1.8× 522 1.1× 108 3.9k
Jorma Hinkula Sweden 38 2.4k 1.6× 1.3k 1.0× 1.1k 1.1× 2.3k 2.6× 1.3k 2.5× 162 4.5k
Simon Beddows United Kingdom 35 1.6k 1.1× 1.0k 0.8× 1.6k 1.5× 955 1.1× 516 1.0× 88 3.6k
Charlene McDanal United States 19 2.8k 1.9× 1.9k 1.4× 681 0.6× 1.2k 1.4× 1.1k 2.2× 24 3.6k
Sanjay Gurunathan United States 28 785 0.5× 1.0k 0.8× 1.8k 1.8× 1.9k 2.2× 1.1k 2.2× 46 4.4k
Pamela A. Kozlowski United States 31 1.5k 1.0× 828 0.6× 1.2k 1.1× 1.8k 2.1× 617 1.3× 76 3.4k
Bimal K. Chakrabarti United States 28 2.4k 1.6× 1.1k 0.8× 886 0.8× 1.8k 2.1× 948 1.9× 55 3.6k
Martin Cranage United Kingdom 34 2.7k 1.8× 1.2k 0.9× 2.2k 2.1× 1.7k 2.0× 610 1.2× 98 4.3k
Michael S. Wyand United States 31 2.4k 1.6× 969 0.7× 1.3k 1.2× 2.1k 2.4× 817 1.7× 53 4.0k
Secondo Sonza Australia 28 2.4k 1.6× 1.7k 1.3× 746 0.7× 1.2k 1.3× 944 1.9× 53 3.8k

Countries citing papers authored by R. Michael Hendry

Since Specialization
Citations

This map shows the geographic impact of R. Michael Hendry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Michael Hendry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Michael Hendry more than expected).

Fields of papers citing papers by R. Michael Hendry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Michael Hendry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Michael Hendry. The network helps show where R. Michael Hendry may publish in the future.

Co-authorship network of co-authors of R. Michael Hendry

This figure shows the co-authorship network connecting the top 25 collaborators of R. Michael Hendry. A scholar is included among the top collaborators of R. Michael Hendry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Michael Hendry. R. Michael Hendry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hendry, R. Michael, et al.. (2023). PROMOSI KESEHATAN TENTANG OBAT AMLODIPIN DAN SIMVASTATIN SERTA CARA PENGGUNAANNYA. 1(12). 1382–1387.
2.
Condit, Richard, Anna‐Lise Williamson, Rebecca Sheets, et al.. (2016). Unique safety issues associated with virus-vectored vaccines: Potential for and theoretical consequences of recombination with wild type virus strains. Vaccine. 34(51). 6610–6616. 32 indexed citations
3.
Clarke, David K., R. Michael Hendry, Vidisha Singh, et al.. (2016). Live virus vaccines based on a vesicular stomatitis virus (VSV) backbone: Standardized template with key considerations for a risk/benefit assessment. Vaccine. 34(51). 6597–6609. 51 indexed citations
4.
Carias, Ann M., Angela J. Fought, Meegan R. Anderson, et al.. (2016). Increases in Endogenous or Exogenous Progestins Promote Virus-Target Cell Interactions within the Non-human Primate Female Reproductive Tract. PLoS Pathogens. 12(9). e1005885–e1005885. 23 indexed citations
6.
Butler, Katherine, Jennifer Morgan, Debra L. Hanson, et al.. (2013). Susceptibility to Repeated, Low-Dose, Rectal SHIV SF162P3 Challenge Is Independent of TRIM5 Genotype in Rhesus Macaques. AIDS Research and Human Retroviruses. 29(7). 1091–1094. 5 indexed citations
7.
Sweeney, Elizabeth, James Mitchell, Wei Luo, et al.. (2011). Hormonal synchronization of the menstrual cycles of pigtail macaques to facilitate biomedical research including modeling HIV susceptibility. Journal of Medical Primatology. 40(3). 164–170. 12 indexed citations
8.
Kersh, Ellen N., Debra R. Adams, Ae S. Youngpairoj, et al.. (2011). T Cell Chemo-Vaccination Effects after Repeated Mucosal SHIV Exposures and Oral Pre-Exposure Prophylaxis. PLoS ONE. 6(4). e19295–e19295. 15 indexed citations
9.
Johnson, J. Erik, John W. Coleman, Narender K. Kalyan, et al.. (2009). In vivo biodistribution of a highly attenuated recombinant vesicular stomatitis virus expressing HIV-1 Gag following intramuscular, intranasal, or intravenous inoculation. Vaccine. 27(22). 2930–2939. 21 indexed citations
10.
Witko, Susan E., J. Erik Johnson, Narender K. Kalyan, et al.. (2009). Refined methods for propagating vesicular stomatitis virus vectors that are defective for G protein expression. Journal of Virological Methods. 164(1-2). 43–50. 4 indexed citations
11.
Coleman, John W., J. Erik Johnson, Farooq Nasar, et al.. (2007). Quantitative multiplex assay for simultaneous detection of the Indiana serotype of vesicular stomatitis virus and HIV gag. Journal of Virological Methods. 143(1). 55–64. 9 indexed citations
12.
Witko, Susan E., J. Erik Johnson, Krista Melville, et al.. (2006). An efficient helper-virus-free method for rescue of recombinant paramyxoviruses and rhadoviruses from a cell line suitable for vaccine development. Journal of Virological Methods. 135(1). 91–101. 53 indexed citations
13.
Guevara, Hugo, Jorge Casseb, Lynn S. Zijenah, et al.. (2002). Maternal HIV-1 Antibody and Vertical Transmission in Subtype C Virus Infection. JAIDS Journal of Acquired Immune Deficiency Syndromes. 29(5). 435–440. 32 indexed citations
14.
Passaro, Douglas J., et al.. (2000). PARAINFLUENZA VIRUS TYPE 4: CASE REPORT AND REVIEW OF THE LITERATURE. The Pediatric Infectious Disease Journal. 19(9). 893–896. 13 indexed citations
15.
Duchini, Andrea, et al.. (2000). Hepatic Decompensation in Patients With Cirrhosis During Infection With Influenza A. Archives of Internal Medicine. 160(1). 113–113. 73 indexed citations
16.
Casseb, Jorge, et al.. (1997). Coinfection with Human Immunodeficiency Virus and Human T‐Cell Lymphotropic Virus Type I: Reciprocal Activation with Clinical and Immunologic Consequences. Clinical Infectious Diseases. 25(5). 1259–1260. 11 indexed citations
17.
Casseb, Jorge, et al.. (1997). Testing Problems in Diagnosing HTLV Infection among Intravenous Drug Users with AIDS in São Paulo City, Brazil. AIDS Research and Human Retroviruses. 13(18). 1639–1641. 11 indexed citations
18.
Morgado, Mariza Gonçalves, Éster Cerdeira Sabino, Eugene G. Shpaer, et al.. (1994). V3 Region Polymorphisms in HIV-1 from Brazil: Prevalence of Subtype B Strains Divergent from North American/European Prototype and Detection of Subtype F. AIDS Research and Human Retroviruses. 10(5). 569–576. 133 indexed citations
19.
Vujcic, Luba K., Kenneth B. Seamon, S. C. Rastogi, et al.. (1991). High Prevalence of Antibodies to the gp120 V3 Region Principal Neutralizing Determinant of HIV-1 MN in Sera from Africa and the Americas. AIDS Research and Human Retroviruses. 7(10). 831–838. 50 indexed citations
20.
Sawyer, Leigh A., David Katzenstein, R. Michael Hendry, et al.. (1990). Possible Beneficial Effects of Neutralizing Antibodies and Antibody-Dependent, Cell-Mediated Cytotoxicity in Human Immunodeficiency Virus Infection. AIDS Research and Human Retroviruses. 6(3). 341–356. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026